Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
Xal-Ease: impact of an ocular hypotensive delivery device on ease of eyedrop administration, patient compliance, and satisfaction
European Journal of Ophthalmology, 11/09/09
Nordmann JP et al. – Reported compliance rates were very high and similar across groups during both treatment periods. After 1 month of use during both treatment periods, more than 70% of subjects reported global satisfaction with Xal–Ease to their physicians. No adverse events associated with the use of Xal–Ease were noted. Xal–Ease generally makes administration of latanoprost or fixed–combination latanoprost/timolol easier compared with the dropper bottle.
Today in Ophthalmology...keeping you current
Receive free subspecialty "5-minute updates" via email
A novel genetic variant of BMP2K contributes to high myopia
Journal of Clinical Laboratory Analysis, 12/07/09
Can central hexagon peak latency provide a clue to fixation within the mfERG
Documenta Ophthalmologica, 12/07/09
Advances in glaucoma surgery
Expert Review of Ophthalmology, 12/07/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


